NCI-2022-05679

A prospective multi-center clinical study evaluating the use of PD G 506 A and the Eagle V1.2 Imaging System for the visualization of carcinoma during breast conserving surgery.

This research study designed to investigate the effectiveness of two medical technologies in breast-conserving surgery. PD G 506 A: a medical dye or contrast agent designed to highlight specific tissues during surgery. Eagle V1.2 Imaging System: a medical imaging device used to visualize the contrast agent and potentially other tissues. The researchers aim to determine whether combining the PD G 506 A and the Eagle V1.2 Imaging System can help surgeons better identify and remove cancerous tissue while preserving healthy breast tissue. If successful, this study could lead to improved surgical precision, potentially resulting in better outcomes for patients with breast cancer.

For more information about the trial, click the link below:

https://clinicaltrials.gov/ct2/show/NCT04815083

Clinical Trial Site: Einstein

To see all available clinical trials click here.